BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 26603490)

  • 1. Celiac disease: Autoimmunity in response to food antigen.
    Stamnaes J; Sollid LM
    Semin Immunol; 2015 Sep; 27(5):343-52. PubMed ID: 26603490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
    Schuppan D; Dennis MD; Kelly CP
    Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
    Koning F; Gilissen L; Wijmenga C
    Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M; Hormaza L; Guandalini S
    Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiac disease--sandwiched between innate and adaptive immunity.
    Stepniak D; Koning F
    Hum Immunol; 2006 Jun; 67(6):460-8. PubMed ID: 16728270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathomechanisms in celiac disease.
    Dieterich W; Esslinger B; Schuppan D
    Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
    Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
    Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the timing of gluten introduction on the development of celiac disease.
    Silano M; Agostoni C; Guandalini S
    World J Gastroenterol; 2010 Apr; 16(16):1939-42. PubMed ID: 20419830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
    Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
    Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
    Lindfors K; Kaukinen K; Mäki M
    Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiac disease: how complicated can it get?
    Tjon JM; van Bergen J; Koning F
    Immunogenetics; 2010 Oct; 62(10):641-51. PubMed ID: 20661732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
    Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
    Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation in celiac disease.
    Qiao SW; Sollid LM; Blumberg RS
    Curr Opin Immunol; 2009 Feb; 21(1):111-7. PubMed ID: 19342211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiac disease: sandwiched between innate and adaptive immune responses induced by gluten.
    Koning F
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E8-9. PubMed ID: 18354329
    [No Abstract]   [Full Text] [Related]  

  • 20. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells.
    Ráki M; Tollefsen S; Molberg Ø; Lundin KE; Sollid LM; Jahnsen FL
    Gastroenterology; 2006 Aug; 131(2):428-38. PubMed ID: 16890596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.